ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 86 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,291,966 | -20.2% | 3,187,420 | +0.2% | 0.00% | 0.0% |
| Q2 2023 | $26,681,827 | +7.5% | 3,180,194 | +27.3% | 0.00% | 0.0% |
| Q1 2023 | $24,816,669 | +43.1% | 2,499,161 | +0.3% | 0.00% | – |
| Q4 2022 | $17,346,193 | +29.1% | 2,492,269 | -0.9% | 0.00% | – |
| Q3 2022 | $13,434,000 | +38.2% | 2,515,884 | +3.2% | 0.00% | – |
| Q2 2022 | $9,723,000 | -26.1% | 2,436,758 | -17.7% | 0.00% | – |
| Q1 2022 | $13,165,000 | +17.0% | 2,961,635 | +5.2% | 0.00% | – |
| Q4 2021 | $11,256,000 | -53.0% | 2,813,924 | +3.2% | 0.00% | -100.0% |
| Q3 2021 | $23,947,000 | -21.6% | 2,727,396 | +1.1% | 0.00% | 0.0% |
| Q2 2021 | $30,551,000 | +25.3% | 2,696,450 | +31.4% | 0.00% | 0.0% |
| Q1 2021 | $24,384,000 | +120.0% | 2,052,495 | +27.0% | 0.00% | – |
| Q4 2020 | $11,086,000 | -9.4% | 1,616,005 | -2.2% | 0.00% | – |
| Q3 2020 | $12,239,000 | +184.2% | 1,651,758 | +59.9% | 0.00% | – |
| Q2 2020 | $4,307,000 | +54.8% | 1,032,971 | -8.3% | 0.00% | – |
| Q1 2020 | $2,783,000 | -57.4% | 1,126,642 | +0.1% | 0.00% | – |
| Q4 2019 | $6,538,000 | +9.9% | 1,125,332 | -0.3% | 0.00% | – |
| Q3 2019 | $5,948,000 | -10.8% | 1,128,617 | +1.5% | 0.00% | – |
| Q2 2019 | $6,671,000 | -30.9% | 1,111,944 | +4.0% | 0.00% | – |
| Q1 2019 | $9,654,000 | +5.8% | 1,069,075 | -2.8% | 0.00% | – |
| Q4 2018 | $9,127,000 | -30.2% | 1,099,620 | +16.0% | 0.00% | -100.0% |
| Q3 2018 | $13,081,000 | +118.2% | 947,876 | +25.7% | 0.00% | – |
| Q2 2018 | $5,995,000 | +14.6% | 754,169 | +8.1% | 0.00% | – |
| Q1 2018 | $5,232,000 | +10.1% | 697,634 | -0.1% | 0.00% | – |
| Q4 2017 | $4,750,000 | +40.0% | 698,534 | +48.3% | 0.00% | – |
| Q3 2017 | $3,392,000 | +137.0% | 471,031 | +54.6% | 0.00% | – |
| Q2 2017 | $1,431,000 | -3.0% | 304,633 | +3.2% | 0.00% | – |
| Q1 2017 | $1,476,000 | +89.5% | 295,226 | +102.9% | 0.00% | – |
| Q4 2016 | $779,000 | -25.3% | 145,472 | +9.5% | 0.00% | – |
| Q3 2016 | $1,043,000 | +46.5% | 132,886 | +6.2% | 0.00% | – |
| Q2 2016 | $712,000 | +40.2% | 125,125 | +3.1% | 0.00% | – |
| Q1 2016 | $508,000 | -36.7% | 121,407 | +2.6% | 0.00% | – |
| Q4 2015 | $802,000 | -99.6% | 118,340 | -97.6% | 0.00% | -100.0% |
| Q3 2015 | $186,567,000 | +23162.7% | 4,869,794 | +4606.5% | 0.01% | – |
| Q2 2015 | $802,000 | – | 103,470 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |